Introduction: After major liver surgery, there are risks of both postoperative bleeding and
Introduction
In recent years, an increasing number of liver resections have been performed as a consequence of the improvement of surgical techniques, medical imaging, and chemotherapy as well as a consequence of changes in the selection criteria [1] . Major hepatic resections have been associated with a high risk of postoperative liver insufficiency, and this risk is directly proportional to the size of the resection. There is also a direct relationship between the degree of liver failure and mortality [2] [3] [4] . Postoperative liver insufficiency may involve coagulation aberrations, and a prolonged postoperative PT-INR is commonly observed following a major hepatectomy. This may be associated with an increased risk of bleeding. Recent retrospective studies report a perioperative bleeding incidence of approximately 6% [5, 6] , and the overall rate of postoperative transfusion is 0.8 % [7] .
In addition, there have been reports of an increased risk of thrombotic complications following hepatic surgery, with an overall incidence of deep venous thrombosis between 0.8% and 3.6% and a pulmonary embolism incidence between 1.4% and 7.1% [7] [8] [9] . Concern about the risk of postoperative bleeding has led to a controversy as to whether routine postoperative thrombosis prophylaxis should be administered [8, 10] . After major hepatic surgery, venous thrombosis has been reported to occur mainly between postoperative days 5 and 7 [9, 11] . These data indicate that patients undergoing major hepatic resections may be affected by a postoperative hypercoagulable state despite the general perception of hypocoagulability indicated by usual coagulation tests, such as PT/INR. Currently, there are no conventional laboratory assays that can predict the occurrence of a venous thromboembolism.
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There are a few prospective studies that focus on defining the coagulation status of patients undergoing major liver surgery. Hypercoagulation has been reported in studies on living liver donors [12] and in patients undergoing liver resections for primary and secondary malignancies [13] .
Thromboelastography (TEG®) is a viscoelastic method for haemostatic testing in whole blood that provides a global assessment of coagulation function. It has long been used postoperatively following cardiac surgery, during liver transplantation, and in acute trauma patients to mainly detect hypocoagulation and to guide transfusion therapy [14] [15] [16] [17] [18] [19] .
Thromboelastography (TEG®) is reported to be able to detect hypercoagulation and predict thromboembolic events in surgical patients [20] [21] [22] . However, there are other reports that have
showed that the predictive capacity may be highly variable [23] .
Rotation thromboelastometry (ROTEM®) is based on the same principle as thromboelastography (TEG®). Depending on the method of initiating coagulation, different types of thromboelastometric curves result, which reflect the intrinsic pathway of coagulation (INTEM), the extrinsic pathway of coagulation (EXTEM), or the fibrinogen functionality (FIBTEM). Nevertheless, there are differences in the sensitivity between TEG® and ROTEM®, and thus, the results are not always comparable [14] . It has recently been found that the functional fibrinogen of TEG® may overestimate fibrinogen levels compared to the plasma fibrinogen concentration [24] .
We prospectively examined consecutive patients scheduled for a major liver resection longitudinally during hospitalization in a descriptive pilot study. We used a battery of routine coagulation-related analyses and ROTEM® and simultaneously recorded the clinical signs of
bleeding and thromboembolism. The protocol extended from preoperative to every 3 rd day, postoperatively.
Our hypothesis was that the combination of routine chemistry and ROTEM® may increase the quality of the surveillance of the coagulation status following liver surgery. The aim of our study was to assess whether ROTEM®, as a global test of coagulation would improve the predictability of postoperative bleeding or pulmonary embolism after hemihepatectomy and extended hemihepatectomy.
Materials and Methods
Subjects
Patients (n=16) scheduled for extensive liver surgery, namely, hemihepatectomy and extended hemihepatectomy, at Karolinska University Hospital Huddinge, were examined. The exclusion criteria were pre-existing coagulopathy and the use of anticoagulation drugs or platelet aggregation inhibitors. The patients' characteristics are provided in Table 1 . The patients provided written informed consent after having been informed about the study protocol, orally and in writing. The protocol was performed in accordance with the Helsinki Declaration and was approved by the Regional Ethics Committee in Stockholm, Sweden. All patients were treated according to the local protocol for liver resections at Karolinska University Hospital and this was not affected by the study. All patients received a thoracic epidural catheter before the induction of general anaesthesia. Ringer-Acetate and Volulyte® (6 % hydroxyethyl starch 130/0.4 in a balanced electrolyte solution) were used as intraoperative fluids. Central venous pressure was kept below 5 cm of water during the hepatic resection. Blood pressure was monitored via a 20G catheter in the left radial artery. All patients were extubated after the surgical procedure, Glucose 5% was administered during the initial 24 hours and as soon as the patients were circulatorily stable enteral nutrition was initiated. Analgesia was administered via an epidural catheter for 5-7 days postoperatively. All patients received thrombosis prophylaxis with Fragmin ® (dalteparin) 5000 IE starting on the day before surgery and continuing regularly every day at 20:00 for as long as the patient was hospitalized.
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Analyses
The following analyses were included at each blood sampling: total serum bilirubin (BIL-T, Conversely, the hypercoagulable state may be indicated by a shortening of the CT and CFT and an increase in MCF [25] .
The ROTEM® assay was performed at the Department of Transfusion Medicine, while the other analyses were performed at the Department of Clinical Chemistry.
Statistics
The GraphPad Prism 5® statistical software package was used (GraphPad Software, Inc., San Diego, CA) for calculations. Statistical comparisons for the coagulation parameters studied were performed for days 0-7 using Friedman's ANOVA and Dunn's post-hoc multiple comparison test.
Results
Patients scheduled for liver resection were studied longitudinally as long as they had a Table 1 . 
Figure 1(A-E).
Perioperative changes in the coagulation parameters for patients undergoing liver surgery (n=16). Panels 1A, 1B and 1C depict the routine chemistry, while panels 1D and 1E depict the ROTEM® parameters. All of the values are expressed as the median and were normalized with preoperative values as 100%. The level of statistical significance for the ANOVAs calculated for the individual parameters are given in the parentheses in the figure panels. For panels 1D and 1E it should be emphasized that although the temporal changes in ROTEM® parameters attained statistical significance, the median values stayed within the normal range the entire study period. All of the numerical values, including sampling after postoperative day 7, are provided in Supporting Information 2 in the electronic supplement.
For the fibrinogen plasma concentration and MCF-FIBTEM, a post-hoc analysis dichotomizing the patients according to the size of the liver resection showed a significant difference. The decrease was more pronounced on postoperative day one and less of a catch-up towards the normal range in the group with extended hemihepatectomy compared with patients with a hemihepatectomy. This finding is illustrated in Figure 2(A, B) . The absolute values for these subjects are provided in electronic supplementary material 3. Two patients who had a thoracic CT scan on postoperative days 5 and 8, respectively, due to increased oxygen administration, were confirmed with the diagnosis of pulmonary embolism.
Both patients underwent right hemihepatectomies. In one of these patients, CT-EXTEM, CFT-EXTEM and MCF-FIBTEM revealed values indicating hypercoagulation prior to the occurrence of a pulmonary embolism. The other patient had a CT-EXTEM towards the hypercoagulation limit, but all of the other ROTEM parameters were within the normal range.
In both patients, there was a rapid rebound of fibrinogen, the values of which exceeded the upper limit of the plasma concentration in one patient on postoperative day 4; however, in the other patient, MCF-FIBTEM had values indicating hypercoagulation on postoperative day 4 and 7. Regarding the anticoagulant proteins in patients that developed a pulmonary embolism,
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Discussion
In this descriptive pilot study, the temporal pattern of the coagulation status of patients undergoing major liver resections was characterized. Both procoagulation and anticoagulation were reflected and compared in relationship to some of the aspects of the clinical course.
Clinically, there were no significant postoperative bleeding episodes. Nevertheless, the PT -INR value and the decreasing plasmatic fibrinogen indicated that patients may have a risk of bleeding on postoperative day 1. However, this finding was not supported by the ROTEM® parameters, which showed that most patients were within the normal range. Importantly, a discrepancy between the results of the conventional coagulation tests and ROTEM® on postoperative day 1 was observed. The decrease in the plasma concentration of fibrinogen and the pro-coagulant factors, was not reflected in the results of CT, CFT and MCF (INTEM and EXTEM), which demonstrated only slight variations in most of the subjects. However, not only the pro-coagulant factors were affected; the levels of the natural anticoagulant proteins (e.g.
protein C, protein S and AT) were also reduced. The haemostatic balance may be maintained when the pro-and anticoagulant system are affected to the same extent [14] . This is probably the most important mechanism behind the fact that the ROTEM® median values remained within the normal range on postoperative day 1. Another factor that affects the ROTEM® parameters, particularly MCF, is platelets. Although lower compared with preoperative values, platelet counts were sufficiently high enough to ensure the good strength of the cloth on postoperative day 1 in most patients. ROTEM® evaluated the viscoelastic properties of noncentrifugal blood, resulting in a global viewpoint over the function of the coagulation system.
All of the blood cells and the complete set of the coagulation components of the plasma were analysed within the same sample. Thus, it must be mentioned that erythrocytes can significantly affect the coagulation process [26, 27] .
On postoperative day 4 and continuing to day 7, there were signs of an imbalance in favour of the procoagulant component in some subjects. This was a reflection of the rapid return to Other investigators have used thromboelastography (TEG®) to detect the potential hypercoagulant status [13, 28, 29] . However, associations with clinically relevant thromboembolic events was not reported, although special coagulation tests like prothrombin fragments 1 and 2, thrombin-antithrombin complexes and plasma von Willebrand Factor antigen performed at the same time, suggest activation of coagulation [13] . The potential hypercoagulation of these patients may be based on the accentuated decrease in anticoagulant proteins accompanied by the rapid resumption of specific procoagulant factors' synthesis, including factor VIII or von Willebrand factor [12, 29] , which are acute phase reactants.
Unexpectedly, our study indicated that with regard to fibrinogen, which is also an acute phase reactant, this argument may be stronger following hemihepatectomy compared to extended hemihepatectomy. This may potentially be related to differences in the volume of the remaining liver tissue because fibrinogen is synthesized mainly by the liver. Thus, it may be speculated that the risk of fibrinogen concentrations reach supranormal values, thereby potentially contributing to hypercoagulation could be more pronounced following a hemihepatectomy. Further studies of this specific aspect are warranted.
A recent study reports brief hypercoagulability on postoperative day one after major hepatectomy with coagulation that was normalized during the following days [30] . We were unable to observe any signs of hypercoagulability on postoperative day one in our patients The strengths of our study are (i) the selected patient group underwent major liver surgery, hemihepactomy or extended hemihepactomy, which is the group that is at risk to develop liver insufficiency, thromboembolism, and/or massive bleeding; (ii) all of the patients received thrombosis prophylaxis, regardless of the clotting test results; and (iii) both pro-and anticoagulant mechanisms were studied longitudinally and biochemically using the thromboelastometric method.
Our study also has several limitations: (i) the protocol did not allow for differentiation between the effects of coagulation by elective surgical trauma, in general, and the effect from the loss of liver tissue; (ii) clotting factors and biomarkers for thrombin generation and fibrinolysis were not analysed; (iii) pulmonary embolisms were not systematically diagnosed using computer tomography for patients who required O 2 administration after surgery; and (iv) echographic screening for deep vein thrombosis in the patients included in this study was not performed.
Furthermore, (v) we did not evaluate the effect of administered synthetic colloids that were routinely used at our hospital at the time of the study on the ROTEM® parameters.
Conclusions
Following major hepatic surgery, there were changes in the routine coagulation parameters.
The addition of ROTEM® analyses indicated that nearly all of the patients had a balanced coagulation status. A potential tendency towards hypercoagulation for individual patients was observed and may be based on an accentuated decrease in anticoagulant proteins, which was accompanied by a rapid return of specific procoagulant factors towards normal levels. The combination of routine coagulation monitoring and ROTEM® analyses may provide a more complete picture of the coagulation status. Although this contributes to our understanding of the coagulation status after major liver surgery, this observational pilot study alone cannot provide support to the routine use of this type of enhanced monitoring in everyday clinical practice in these patients. Thus, studies that systematically combine postoperative thromboembolic related complications and enhanced monitoring will be necessary to support such a recommendation. It was also observed post-hoc that the size of liver resection may be a factor to consider and that postoperative fibrinogen trends are different between hemihepatectomy and extended hepatectomy.
